These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Consequences of abrupt reduction of chronic symptoms. Satel SL; Southwick S Am J Psychiatry; 1987 Oct; 144(10):1362. PubMed ID: 3661773 [No Abstract] [Full Text] [Related]
63. Comparison of pharmacological treatment response between situational and non-situational depressions. Garvey MJ; Schaffer CB; Tuason VB Br J Psychiatry; 1984 Oct; 145():363-5. PubMed ID: 6435711 [TBL] [Abstract][Full Text] [Related]
64. Clinical psychopharmacology and medical malpractice: the four Ds. Preskorn SH J Psychiatr Pract; 2014 Sep; 20(5):363-8. PubMed ID: 25226197 [TBL] [Abstract][Full Text] [Related]
65. Comparative effects of seven antidepressant regimes on appetite, weight and carbohydrate preference. Harris B; Young J; Hughes B Br J Psychiatry; 1986 May; 148():590-2. PubMed ID: 3779231 [TBL] [Abstract][Full Text] [Related]
66. Alprazolam and desipramine in moderately severe depression. McCormick WO Can J Psychiatry; 1986 May; 31(4):378. PubMed ID: 3708532 [No Abstract] [Full Text] [Related]
67. Serum haloperidol and desipramine concentrations and the treatment of psychotic depression: two case reports. Lin KM; Poland RE; Fu P; Nuccio I; Lesser IM J Nerv Ment Dis; 1989 Jul; 177(7):431-2. PubMed ID: 2746195 [No Abstract] [Full Text] [Related]
68. Disputing preliminary findings on methylphenidate-desipramine responses. Mattes JA Am J Psychiatry; 1983 Sep; 140(9):1273. PubMed ID: 6614262 [No Abstract] [Full Text] [Related]
70. A double-blind study of desipramine (Norpramin) with imipramine (Tofranil) with clinical, psychological observations and cross-overs. Agin HV; Greenblatt IJ; Agin MJ Psychosomatics; 1965; 6(5):320-1. PubMed ID: 5319242 [No Abstract] [Full Text] [Related]
71. Noninvasive measurement of cardiac ejection fraction during desipramine treatment. Murburg M; Anton RF; Nelson JC; Jatlow PI Psychosomatics; 1982 Jul; 23(7):759-61. PubMed ID: 7122806 [No Abstract] [Full Text] [Related]
73. Antidepressants in the treatment of PTSD. Frank JB; Kosten TR; Giller EL Am J Psychiatry; 1990 Feb; 147(2):260. PubMed ID: 2301678 [No Abstract] [Full Text] [Related]
74. THE USE OF "PERTOFRAN" IN DEPRESSION: A SHORT COMMUNICATION. FRAME MC Med J Aust; 1963 Aug; 2():356-7. PubMed ID: 14048436 [No Abstract] [Full Text] [Related]
75. Quetelet's Index and appetite and weight change in the context of depression. Harris B; Young JP; Hughes W Br J Psychiatry; 1986 Oct; 149():522-3. PubMed ID: 3814943 [No Abstract] [Full Text] [Related]
76. Growth deficits and desipramine. Holt KG J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1167-8. PubMed ID: 1429424 [No Abstract] [Full Text] [Related]
77. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine. Millichap JG Pediatrics; 1978 Jan; 61(1):146-7. PubMed ID: 263851 [No Abstract] [Full Text] [Related]
78. Growth deficits in children treated with desipramine: a controlled study. Spencer T; Biederman J; Wright V; Danon M J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):235-43. PubMed ID: 1564024 [TBL] [Abstract][Full Text] [Related]
79. ECG changes in pediatric patients on tricyclic antidepressants, desipramine, and imipramine. Johnson A; Giuffre RM; O'Malley K Can J Psychiatry; 1996 Mar; 41(2):102-6. PubMed ID: 8705955 [TBL] [Abstract][Full Text] [Related]
80. Pharmacotherapy and behaviour therapy--competition or cooperation? van Engeland H Acta Paedopsychiatr; 1993; 56(2):123-7. PubMed ID: 8135110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]